Rosuvastatin Completed Phase 2 Trials for Ischaemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00315510Rosuvastatin and Ischemia Reperfusion